BM
BRETT MEEKS
HORIZON GOVERNMENT AFFAIRS · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
5
last 3 years
Filings
20
5 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Former Deputy Health Policy Director for the Senate Committee on Health
Education, Labor and Pensions
Disclosed on LD-2 filings
Former Deputy Health Policy Director for Senate Committee on Health
Education, Labor and Pensions.
Disclosed on LD-2 filings
Career
HG
Specific issues
Issues related to insurance agent and broker fees in Medicare, Proposed Rule-Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-P) and Final Rule - Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-F)
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software, including the American Privacy Rights Act; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development, including the Telehealth Modernization Act (H.R. 7623); Issues related to the use of artificial intelligence in health care.
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule including the Telehealth Modernization Act (H.R. 7623). Regulation of laboratory-developed tests, including the FDAs final rule, Docket No. FDA-2023-N-2177. Issues relating to value-based arrangements for lab testing. Issues related to the use of artificial intelligence in health care.
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors' Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services, broadband access and infrastructure development; Issues related to the use of artificial intelligence in health care.
Clients
Filing history
INTEGRITY MARKETING GROUP
HEALTH INNOVATION ALLIANCE
CENCORA FKA AMERISOURCEBERGEN CORPORATION
INTEGRITY MARKETING GROUP
HEALTH INNOVATION ALLIANCE
LABORATORY ACCESS & BENEFITS (LAB) COALITION
CENCORA FKA AMERISOURCEBERGEN CORPORATION
CENCORA FKA AMERISOURCEBERGEN CORPORATION
INTEGRITY MARKETING GROUP
LABORATORY ACCESS & BENEFITS (LAB) COALITION
HEALTH INNOVATION ALLIANCE
HEALTH INNOVATION ALLIANCE